🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with numerous of participants share comparison photos, administration instructions and claims of next-day British shipping. Vendors promote the substance there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or imprisonment.

Platform Response and Content Removal

According to TikTok, the service has taken down problematic content and banned related hashtags and query recommendations. The company said it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Research also found communities with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of members, populated with images of weight loss, positive reviews and detailed instructions for mixing or administering at residence.

After minutes of entering one community, a seller shared contact information, where most transactions take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Product Information and Costs

Inside these communities, posts display dark colored packages with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When asked how much time a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service stated it regularly monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they can’t verify. Although the science behind this drug is sound, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in interest to current cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has previously seen individuals injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to possibly significant medical dangers”.